[go: up one dir, main page]

SG11201607600TA - Vaginal composition and use thereof - Google Patents

Vaginal composition and use thereof

Info

Publication number
SG11201607600TA
SG11201607600TA SG11201607600TA SG11201607600TA SG11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA
Authority
SG
Singapore
Prior art keywords
vaginal composition
vaginal
composition
Prior art date
Application number
SG11201607600TA
Inventor
Zhongming Zeng
Ruyun Zhou
Original Assignee
Singapore Ze&Z Internat Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54070942&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201607600T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Singapore Ze&Z Internat Pte Ltd filed Critical Singapore Ze&Z Internat Pte Ltd
Publication of SG11201607600TA publication Critical patent/SG11201607600TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11201607600TA 2014-03-13 2015-03-11 Vaginal composition and use thereof SG11201607600TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410103662 2014-03-13
PCT/CN2015/073978 WO2015135470A1 (en) 2014-03-13 2015-03-11 Composition for vagina and use of the composition

Publications (1)

Publication Number Publication Date
SG11201607600TA true SG11201607600TA (en) 2016-10-28

Family

ID=54070942

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201607600TA SG11201607600TA (en) 2014-03-13 2015-03-11 Vaginal composition and use thereof
SG10201807789WA SG10201807789WA (en) 2014-03-13 2015-03-11 Vaginal composition and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201807789WA SG10201807789WA (en) 2014-03-13 2015-03-11 Vaginal composition and use thereof

Country Status (7)

Country Link
US (2) US10869878B2 (en)
EP (1) EP3117827B1 (en)
CN (2) CN110840903B (en)
CA (1) CA2942424C (en)
MY (1) MY192494A (en)
SG (2) SG11201607600TA (en)
WO (1) WO2015135470A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230165382A (en) * 2015-09-29 2023-12-05 킴벌리-클라크 월드와이드, 인크. Composition for maintaining loctobacillus dominance
WO2017058175A1 (en) 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
EP3272333A1 (en) * 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
MX389431B (en) 2017-02-28 2025-03-20 Kimberly Clark Co SYNERGIC COMPOSITION FOR MAINTAINING A HEALTHY MICROFLORA BALANCE.
CN109589404A (en) * 2018-11-27 2019-04-09 杭州元研细胞生物科技有限公司 One kind is for anti-ageing reparation product of female reproductive system and preparation method thereof
CA3167761C (en) * 2020-02-12 2025-05-20 Shenzhen Eulikan Biotechnology Co., Ltd Bacteriostatic composition, preparation method therefor and use thereof
KR20230047399A (en) * 2020-07-23 2023-04-07 킴벌리-클라크 월드와이드, 인크. How to modulate the bladder microbiome to improve bladder health
CN112870335A (en) * 2021-03-24 2021-06-01 广州修美生物科技有限公司 Bioactive composition, application thereof and tablet prepared from composition
CN113308402A (en) * 2021-05-25 2021-08-27 江苏恒康生物科技有限公司 Probiotic high-density fermentation composition for relieving side effects of multi-kinase inhibitor
CN119768174A (en) * 2022-07-29 2025-04-04 金伯利-克拉克环球有限公司 Methods and compositions related to prebiotic formulations useful for promoting urogenital health

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390803A (en) * 1972-07-18 1975-04-16 Wootton L W Medicinal tampons and compositions containing lactulose
DE69831609T2 (en) 1997-11-24 2006-02-02 Zeng, Zhongming, Shenzhen PHARMACEUTICAL COMPOSITION FOR STIMULATING THE GROWTH OF GRAM-POSITIVE BACILS AND FOR INCREASING THE AZIDITY OF VAGINA AND ITS USE
US6989163B2 (en) * 2001-10-23 2006-01-24 40 J's Llc Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol
EP1462011A1 (en) 2003-03-24 2004-09-29 Cerestar Holding B.V. Comestibles containing Isomaltulose and Trehalose for sustained carbohydrate energy release and reduced glycemic/insulinimic responses
EP1605782A1 (en) * 2003-03-24 2005-12-21 Cerestar Holding B.V. Comestibles containing isomaltulose and trehalose for sustained carbohydrate energy release and reduced glycemic/insulinemic responses, and for preserving osmolality
DE10349465B4 (en) * 2003-10-23 2014-04-03 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gelatin-free, isomaltulose-containing soft caramel
DK1506781T3 (en) 2003-11-03 2005-06-13 Peter-Hansen Volkmann Vaginal care composition
FR2874825B1 (en) 2004-09-08 2006-12-08 Genibio Sarl USES OF BENEFICIAL PREBIOTIC OLIGOSACCHARIDES FOR VAGINAL FLORA
SE528382C2 (en) 2004-10-05 2006-10-31 Probi Ab Probiotic lactobacillus strains for improved vaginal health
EP1714660A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
BRPI0612968A2 (en) * 2005-04-27 2010-12-14 Shenzhen Phlora Biotechnology Ltd use of benzoic acid and / or its sodium salt in combination with saccharides, vaginal composition and method for modulating vaginal flora and vaginal acidity
CA2637608A1 (en) * 2006-01-20 2007-07-26 Pear Tree Pharmaceuticals, Inc. Method of treating atrophic vaginitis
US8221774B2 (en) 2006-06-12 2012-07-17 The Procter & Gamble Company Lotioned wipe product to reduce adhesion of soils or exudates to the skin
WO2010039054A1 (en) * 2008-09-30 2010-04-08 Dikovskiy Aleksander Vladimiro Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
IT1398279B1 (en) 2009-06-25 2013-02-22 Bsd PHARMACEUTICAL FORMULATIONS FOR INTRAVAGINAL USE IN THE PREVENTION AND THERAPY OF VAGINITE VULVUSES AND IN THE RESTORATION OF VAGINAL PHYSIOLOGY
FI122247B (en) 2009-08-12 2011-10-31 Vetcare Oy Probiotic preparation for the prevention or treatment of dogs gastrointestinal disorders
US8765819B2 (en) 2009-10-08 2014-07-01 Zhongming Zeng Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
US8223571B2 (en) 2010-07-20 2012-07-17 Taiwan Semiconductor Manufacturing Company, Ltd. Generating and amplifying differential signals
ES2702490T3 (en) 2011-05-03 2019-03-01 Dupont Nutrition Biosci Aps Probiotic bacteria for the topical treatment of skin disorders
CN102370598A (en) 2011-09-30 2012-03-14 天津市中科健新材料技术有限公司 Prebiotics deodorant finishing liquor for wet tissues
JP5927663B2 (en) 2011-10-21 2016-06-01 松谷化学工業株式会社 Saccharide composition and food / beverage product whose blood glucose level rises gradually
IN2014DN03449A (en) * 2011-11-30 2015-06-05 Meiji Co Ltd

Also Published As

Publication number Publication date
US10869878B2 (en) 2020-12-22
US20210077516A1 (en) 2021-03-18
EP3117827A1 (en) 2017-01-18
CA2942424A1 (en) 2015-09-17
MY192494A (en) 2022-08-24
SG10201807789WA (en) 2018-10-30
US11951116B2 (en) 2024-04-09
EP3117827A4 (en) 2017-12-20
CA2942424C (en) 2019-12-31
CN107073019B (en) 2020-04-17
CN110840903B (en) 2021-08-31
CN110840903A (en) 2020-02-28
WO2015135470A1 (en) 2015-09-17
US20160375045A1 (en) 2016-12-29
CN107073019A (en) 2017-08-18
EP3117827B1 (en) 2021-11-03

Similar Documents

Publication Publication Date Title
GB201411197D0 (en) Composition and use thereof
PL3018183T3 (en) Haloolefin-based composition and use thereof
IL247713A0 (en) 5-substituted indazole-3-carboxamides and preparation and use thereof
IL250568B (en) Anti-methanogenic compositions and uses thereof
IL247014A0 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof
PL3152226T3 (en) Modified cyclopentapeptides and uses thereof
GB201401617D0 (en) Novel combination and use
SI3233105T1 (en) Novel combination and use
SG11201607600TA (en) Vaginal composition and use thereof
PL3194656T3 (en) Sealing-strip holder and use thereof
SG11201608217PA (en) Fatty acid composition and use thereof
IL283335B (en) Dihydropyrimidin-2-one compounds and medical use thereof
ZA201704105B (en) Refractories and use thereof
GB201411196D0 (en) Composition and use thereof
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
PT3129398T (en) New medical agents and uses thereof
IL251238B (en) Mineral based compositions and use thereof
DK3145548T3 (en) Aqueous gel composition and its use
GB201420805D0 (en) Ligatures and use thereof
GB2530711B (en) Security composition and use thereof
GB2545167B (en) Cloches and use thereof
PL3229772T3 (en) 6-aryl-9-glycosylpurines and use thereof
GB201500278D0 (en) Novel combination and use
GB201413411D0 (en) Novel compounds and their use
GB201514770D0 (en) Compounds and their use